NeuroPace (NPCE) Change in Receivables (2020 - 2026)
NeuroPace's quarterly Change in Receivables came in at $108000.0 in Q1 2026, down 95.82% year-on-year from $2.6 million in Q1 2025, and up 142.02% quarter-over-quarter from -$257000.0 in Q4 2025.
NeuroPace has reported Change in Receivables for 7 years, with the latest figure at $108000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables fell 95.82% year-over-year to $108000.0; the trailing twelve-month figure through Mar 2026 stood at -$647000.0 (down 117.01% YoY), and the FY2025 full-year result was $1.8 million, up 241.42% from the prior year.
- Change in Receivables for Q1 2026 stood at $108000.0, up from -$257000.0 in the prior quarter.
- The five-year high for Change in Receivables was $2.6 million in Q1 2025, with the low at -$1.9 million in Q2 2025.
- Average Change in Receivables over 5 years is $453823.5, with a median of $318000.0 recorded in 2024.
- Year-over-year, Change in Receivables soared 1115.46% in 2022 and sank 383.55% in 2025.
- Tracing NPCE's Change in Receivables over 5 years: stood at -$392000.0 in 2022, then jumped by 368.37% to $1.1 million in 2023, then advanced by 22.53% to $1.3 million in 2024, then tumbled by 119.94% to -$257000.0 in 2025, then soared by 142.02% to $108000.0 in 2026.
- The last three Change in Receivables figures came in at $108000.0 (Q1 2026), -$257000.0 (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -13.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -124.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 123.50 Mn |
| 10 | NeuroPace | 558.86 Mn | 504.88 Mn | 18.05 Mn | 108,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 108,000.00 |
| Mar 31, 2026 | 108,000.00 |
| Dec 31, 2025 | -257,000.00 |
| Dec 31, 2025 | -257,000.00 |
| Sep 30, 2025 | 1.38 Mn |
| Sep 30, 2025 | 1.38 Mn |
| Jun 30, 2025 | -1.88 Mn |
| Jun 30, 2025 | -1.88 Mn |
| Mar 31, 2025 | 2.59 Mn |
| Mar 31, 2025 | 2.59 Mn |
| Dec 31, 2024 | 1.29 Mn |
| Dec 31, 2024 | 1.29 Mn |
| Sep 30, 2024 | 318,000.00 |
| Sep 30, 2024 | 318,000.00 |
| Jun 30, 2024 | -389,000.00 |
| Jun 30, 2024 | -389,000.00 |
| Mar 31, 2024 | -682,000.00 |
| Mar 31, 2024 | -682,000.00 |
| Dec 31, 2023 | 1.05 Mn |
| Dec 31, 2023 | 1.05 Mn |
| Sep 30, 2023 | 403,000.00 |
| Sep 30, 2023 | 403,000.00 |
| Jun 30, 2023 | 1.68 Mn |
| Jun 30, 2023 | 1.68 Mn |
| Mar 31, 2023 | 1.71 Mn |
| Mar 31, 2023 | 1.71 Mn |
| Dec 31, 2022 | -392,000.00 |
| Dec 31, 2022 | -392,000.00 |
| Sep 30, 2022 | -601,000.00 |
| Sep 30, 2022 | -601,000.00 |
| Jun 30, 2022 | -586,000.00 |
| Jun 30, 2022 | -586,000.00 |
| Mar 31, 2022 | 1.97 Mn |
| Mar 31, 2022 | 1.97 Mn |
| Dec 31, 2021 | 480,000.00 |
| Dec 31, 2021 | 480,000.00 |
| Sep 30, 2021 | -1.09 Mn |
| Sep 30, 2021 | -1.09 Mn |
| Jun 30, 2021 | -496,000.00 |
| Jun 30, 2021 | -496,000.00 |
| Mar 31, 2021 | -194,000.00 |
| Mar 31, 2021 | -194,000.00 |
| Dec 31, 2020 | 340,000.00 |
| Dec 31, 2020 | 340,000.00 |
| Sep 30, 2020 | 2.01 Mn |
| Sep 30, 2020 | 2.01 Mn |
| Jun 30, 2020 | -165,000.00 |
| Jun 30, 2020 | -165,000.00 |
| Mar 31, 2020 | 197,000.00 |
| Mar 31, 2020 | 197,000.00 |